GI NOTES
GI Medication Quick Guide
Key points
- Take PPIs 30 to 60 minutes before a meal; review every long-term prescription for a clear indication.
- Around endoscopy, stopping or continuing antithrombotics depends on both bleeding risk of the procedure and clot risk of the patient.
- Patients on GLP-1 receptor agonists may have retained food; a liquid diet the day before is a common approach.
- Before starting biologics or JAK inhibitors, screen for TB and hepatitis B and update vaccines.
- In cirrhosis, avoid NSAIDs, and use non-selective beta-blockers, lactulose and rifaximin where indicated.
1. Acid suppression
- Clear long-term indications: erosive esophagitis LA grade C or D, Barrett’s esophagus, eosinophilic esophagitis responding to PPI, ulcer prevention in high-risk NSAID or antiplatelet users, idiopathic peptic ulcer.
- Deprescribing: for uncomplicated GERD that has resolved, taper or stop and use on-demand dosing. Rebound symptoms are common for 2 to 4 weeks.
- Potassium-competitive acid blockers (vonoprazan) are approved for erosive esophagitis and as part of H. pylori regimens.
- Reported associations with long-term PPIs (fractures, kidney disease, dementia) are mostly from observational data; the strongest real risks are C. difficile infection and low magnesium or B12.
2. Antithrombotics around elective endoscopy
FIGURE: PLANNING ANTITHROMBOTICS BEFORE ENDOSCOPY
Elective procedure: what is the bleeding risk?
Low risk
Diagnostic EGD or colonoscopy, biopsies, small polyp cold snare
→ Usually continue
Diagnostic EGD or colonoscopy, biopsies, small polyp cold snare
→ Usually continue
High risk
Large polypectomy, sphincterotomy, EUS-FNA, PEG, dilation
→ Plan holds with cardiology
Large polypectomy, sphincterotomy, EUS-FNA, PEG, dilation
→ Plan holds with cardiology
Aspirin for secondary prevention: continue. Recent stent (DES under 6 to 12 months): delay elective procedure if possible.
Original diagram based on the ACG-CAG 2022 periendoscopic antithrombotic guideline.
| Drug | Typical hold before high-risk procedure | Notes |
|---|---|---|
| Warfarin | 5 days; check INR | Bridging heparin is generally not recommended except in selected very high-risk patients (such as mechanical mitral valves) |
| Apixaban, rivaroxaban, edoxaban | 1 to 2 days (longer with reduced kidney function) | No bridging; restart once hemostasis is secure |
| Dabigatran | 2 to 4 days depending on kidney function | Mostly cleared by the kidneys |
| Clopidogrel, prasugrel, ticagrelor | 5 days (prasugrel 7) | Continue aspirin; never stop dual therapy early after a coronary stent without cardiology |
3. Before procedures and treatment
- GLP-1 receptor agonists (semaglutide, tirzepatide, others): slow gastric emptying. Current multisociety guidance favors continuing in most patients, with a liquid diet for 24 hours before the procedure; consider holding in those with GI symptoms or at high risk of retained food.
- Bowel preparation: split dosing (half the evening before, half 4 to 6 hours before the procedure) gives the best results; finish at least 2 hours before sedation. Avoid sodium phosphate in kidney disease.
- Before biologics or JAK inhibitors: TB screening (interferon-gamma release assay), hepatitis B serology, HIV and varicella status, update vaccines (no live vaccines once treatment starts), check TPMT before thiopurines.
4. Cirrhosis medicines at a glance
| Medicine | Use | Common starting dose |
|---|---|---|
| Carvedilol | Prevent first variceal bleed; portal hypertension | 6.25 mg daily, up to 12.5 mg daily |
| Spironolactone with furosemide | Ascites | 100 mg and 40 mg daily (ratio 100:40) |
| Lactulose | Hepatic encephalopathy | Titrate to 2 to 3 soft stools a day |
| Rifaximin | Prevent recurrent encephalopathy, added to lactulose | 550 mg twice daily |
| Ceftriaxone | Prophylaxis during GI bleeding in cirrhosis | 1 g daily up to 7 days |
| Albumin | Large-volume paracentesis; SBP; hepatorenal syndrome | 6 to 8 g per liter removed when over 5 L |
- Avoid in cirrhosis: NSAIDs, ACE inhibitors and ARBs in ascites, aminoglycosides, benzodiazepines where possible.
- Acetaminophen up to 2 g a day is generally considered safe.
Self-check questions
- A patient on apixaban with normal kidney function needs a large polypectomy. How long to hold, and is bridging needed?
- When should a PPI be taken?
- What screening is needed before starting infliximab?
- A patient with cirrhosis and ascites has knee pain. Which painkiller is preferred?
Answers: (1) About 1 to 2 days; no bridging. (2) 30 to 60 minutes before a meal. (3) TB (IGRA), hepatitis B serology, vaccine review. (4) Acetaminophen at a reduced daily dose; avoid NSAIDs.
References
- Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors. Gastroenterology. 2022;162(4):1334-1342.
- Abraham NS, Barkun AN, Sauer BG, et al. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period. Am J Gastroenterol. 2022;117(4):542-558.
- Kindel TL, Wang AY, Wadhwa A, et al. Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period. Clin Gastroenterol Hepatol. 2024 (published online October 29, 2024). doi:10.1016/j.cgh.2024.10.003.
- Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the AASLD. Hepatology. 2021;74(2):1014-1048.
- Saltzman JR, Cash BD, Pasha SF, et al. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015;81(4):781-794.
For educational purposes only. This note does not replace clinical judgment or local protocols. Check doses against current labeling and institutional guidance.

